Back
Amplify Treatments, Testing and Adv ETF Stock Price Chart
Buy
59
GERM
Amplify Treatments, Testing and Adv ETF
Last Price:
19.06
Seasonality Move:
10.7%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is moderately bullish and GERM is experiencing buying pressure, which is a positive indicator for future bullish movement.
Amplify Treatments, Testing and Adv ETF Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.77 | Buy |
20-day SMA: | 17.97 | Buy |
50-day SMA: | 17.89 | Buy |
200-day SMA: | 18.15 | Buy |
8-day EMA: | 18.88 | Buy |
20-day EMA: | 18.3 | Buy |
50-day EMA: | 18.04 | Buy |
200-day EMA: | 18.63 | Buy |
Amplify Treatments, Testing and Adv ETF Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.45 | Buy |
Relative Strength Index (14 RSI): | 67.73 | Buy |
Chaikin Money Flow: | 274 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.7 - 18.68) | Buy |
Bollinger Bands (100): | (17.52 - 19.16) | Buy |
Amplify Treatments, Testing and Adv ETF Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Amplify Treatments, Testing and Adv ETF Stock
Is Amplify Treatments, Testing and Adv ETF Stock a Buy?
- Amplify Treatments, Testing and Adv ETF share price is 19.23 while GERM 8-day simple moving average is 18.77, which is a Buy signal.
- The stock price of GERM is 19.23 while Amplify Treatments, Testing and Adv ETF 20-day SMA is 17.97, which makes it a Buy.
- Amplify Treatments, Testing and Adv ETF 50-day simple moving average is 17.89 while GERM share price is 19.23, making it a Buy technically.
- GERM stock price is 19.23 and Amplify Treatments, Testing and Adv ETF 200-day simple moving average is 18.15, creating a Buy signal.
GERM Technical Analysis vs Fundamental Analysis
Buy
59
Amplify Treatments, Testing and Adv ETF (GERM)
is a Buy
Is Amplify Treatments, Testing and Adv ETF a Buy or a Sell?
-
Amplify Treatments, Testing and Adv ETF stock is rated a Buy
The current Amplify Treatments, Testing and Adv ETF [GERM] share price is $19.23. The Score for GERM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Amplify Treatments, Testing and Adv ETF Stock Info
Market Cap:
0
Price in USD:
19.23
Share Volume:
274
Amplify Treatments, Testing and Adv ETF 52-Week Range
52-Week High:
21.48
52-Week Low:
15.67
Buy
59
Amplify Treatments, Testing and Adv ETF (GERM)
is a Buy
Amplify Treatments, Testing and Adv ETF Share Price Forecast
-
What is the Amplify Treatments, Testing and Adv ETF stock price today?
The Amplify Treatments, Testing and Adv ETF stock price is 19.23 USD today. -
Will GERM stock go up or go down?
Amplify Treatments, Testing and Adv ETF> share price is forecast to RISE/FALL based on technical indicators -
Is Amplify Treatments, Testing and Adv ETF overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amplify Treatments, Testing and Adv ETF is not overvalued.
Is Amplify Treatments, Testing and Adv ETF Stock a Buy?
- Amplify Treatments, Testing and Adv ETF share price is 19.23 while GERM 8-day exponential moving average is 18.88, which is a Buy signal.
- The stock price of GERM is 19.23 while Amplify Treatments, Testing and Adv ETF 20-day EMA is 18.30, which makes it a Buy.
- Amplify Treatments, Testing and Adv ETF 50-day exponential moving average is 18.04 while GERM share price is 19.23, making it a Buy technically.
- GERM stock price is 19.23 and Amplify Treatments, Testing and Adv ETF 200-day simple moving average is 18.63, creating a Buy signal.
Technical Analysis of Amplify Treatments, Testing and Adv ETF
Should I short Amplify Treatments, Testing and Adv ETF stock?
- GERM Moving Average Covergence Divergence (MACD) indicator is 0.45, suggesting Amplify Treatments, Testing and Adv ETF is a Buy
- Amplify Treatments, Testing and Adv ETF Relative Strength Index (RSI) is 67.73, which suggest Amplify Treatments, Testing and Adv ETF is overbought
- The Bollinger Bands (25) for Amplify Treatments, Testing and Adv ETF is (16.7 - 18.68), which suggest Amplify Treatments, Testing and Adv ETF is a Buy
- The Bollinger Bands (100) for Amplify Treatments, Testing and Adv ETF is (17.52 - 19.16), which suggest Amplify Treatments, Testing and Adv ETF is a Buy
* Amplify Treatments, Testing and Adv ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.